LOGIN
COA2017: IA TXA and IV TXA demonstrate similar results for blood loss in total hip arthroplasty
June 2017
COA2017: IA TXA and IV TXA demonstrate similar results for blood loss in total hip arthroplasty
Study Type:Randomized Trial
OE Level Evidence:N/A
Journal Level of Evidence:N/A
Intravenous and topical tranexamic acid acid in primary total hip arthroplasty: the tranexamic acid comparison in hip replacement (TeACH-R) ranomized controlled trial
Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
CONFERENCE ACE REPORTS
This ACE Report is a summary of a conference presentation or abstract. The information provided has limited the ability to provide an accurate assessment of the risk of bias or the overall quality. Please interpret the results with caution as trials may be in progress and select results may have been presented.
Synopsis
124 patients scheduled for cementless total hip arthroplasty were randomized to be administered either intraarticular tranexamic acid or intravenous tranexamic acid. Patients were assessed for total blood loss, maximum haemoglobin drop, the incidence of transfusion, and the incidence of thromboembolic complications. Results demonstrated no significant differences between groups for either blood lo...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Join the Conversation
Please Login or Join to leave comments.